Updates are available Correction dated 2021-02-26
Click to view Correction: https://doi.org/10.1007/s00228-021-03117-w
-
Authors
Razavizadeh, Akram Sadat
Zamani, Nasim
Ziaeefar, Pardis
Ebrahimi, Sara
Hassanian-Moghaddam, Hossein http://orcid.org/0000-0003-4370-0544
-
Funding
Funding for this research was provided by:
National Institute for Medical Research Development
- License Information
-
More Information
Article History
Received: 18 August 2020
Accepted: 23 October 2020
First Online: 30 October 2020
Change Date: 26 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00228-021-03117-w
Compliance with ethical standards
:
: The authors declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.
: The study was approved by the ethics committee in National Institute for Medical Research Development (IR.NIMAD.REC.1397.305) and registered in Iranian Clinical Trial Registry (IRCT20120629010133N3).
: Patients’ relatives accompanying them to ED were explained about the process of the study and written informed consents were taken from them all before patient enrollment. Patients that were awake after the initial flumazenil administration give consent for themselves as well. All data are de-identified in this database to remove patients’ information. Ethic committee waived consent for publication with this conditional issue.
